United States: Pryor Cashman Represents Marina Biotech In Acquisition Of Prestalia® Assets
Last Updated: June 7 2017

On June 6, 2017, it was announced that Marina Biotech, Inc. (OTCQB: MRNA) – a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, acquired Prestalia®, a treatment of hypertension, from Symplmed Pharmaceuticals LLC.

Prestalia may be used in patients whose blood pressure is not adequately controlled on monotherapy, and it may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals. Prestalia is protected by two patents listed in the U.S. FDA's publication, Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. The two Prestalia U.S. patents offer the potential for product exclusivity until 2029.

It is anticipated that Prestalia will be marketed using Symplmed's patented telehealth technology platform, DyrctAxess", which enables direct delivery of medications to a patient's home and helps to address the problem of poor compliance resulting from unfilled prescriptions.

The Pryor Cashman Team

Representing Marina Biotech in this deal were Pryor Cashman Partner Lawrence Remmel and Counsel Michael T. Campoli – both of whom are members of the firm's nationally-recognized Corporate Group.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Karen Robson
By Jeffrey Alberts, Ingrid He
By Pryor Cashman LLP
By Ronald Shechtman
By E. Scott Schirick
By Michael Campoli
By William Thomashower
By Jeffrey Alberts
By Ingrid He
By Pryor Cashman LLP
Font Size: